436 related articles for article (PubMed ID: 21205285)
1. Epidemiology of gout.
Roddy E; Doherty M
Arthritis Res Ther; 2010; 12(6):223. PubMed ID: 21205285
[TBL] [Abstract][Full Text] [Related]
2. [Epidemiology and risk factors for gout].
Gnjidić Z
Reumatizam; 2012; 59(2):82-8. PubMed ID: 23745462
[TBL] [Abstract][Full Text] [Related]
3. The changing epidemiology of gout.
Roddy E; Zhang W; Doherty M
Nat Clin Pract Rheumatol; 2007 Aug; 3(8):443-9. PubMed ID: 17664951
[TBL] [Abstract][Full Text] [Related]
4. Hypertension, its treatment, hyperuricaemia and gout.
Gibson TJ
Curr Opin Rheumatol; 2013 Mar; 25(2):217-22. PubMed ID: 23370375
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of gout.
Roddy E; Choi HK
Rheum Dis Clin North Am; 2014 May; 40(2):155-75. PubMed ID: 24703341
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of gout and chondrocalcinosis.
Ciancio G; Bortoluzzi A; Govoni M
Reumatismo; 2012 Jan; 63(4):207-20. PubMed ID: 22303527
[TBL] [Abstract][Full Text] [Related]
7. New insights into the epidemiology of gout.
Doherty M
Rheumatology (Oxford); 2009 May; 48 Suppl 2():ii2-ii8. PubMed ID: 19447779
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the epidemiology of gout.
Saag KG; Mikuls TR
Curr Rheumatol Rep; 2005 Jun; 7(3):235-41. PubMed ID: 15919001
[TBL] [Abstract][Full Text] [Related]
9. [Current epidemiology of gout].
Ankli B
Ther Umsch; 2016; 73(3):125-9. PubMed ID: 27008443
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, risk factors, and lifestyle modifications for gout.
Saag KG; Choi H
Arthritis Res Ther; 2006; 8 Suppl 1(Suppl 1):S2. PubMed ID: 16820041
[TBL] [Abstract][Full Text] [Related]
11. [Hyperuricemia and Gout].
Delbarba E; Terlizzi V; Dallera N; Izzi C; Scolari F
G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960024
[TBL] [Abstract][Full Text] [Related]
12. Gout and hyperuricemia.
Roubenoff R
Rheum Dis Clin North Am; 1990 Aug; 16(3):539-50. PubMed ID: 2217957
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of hyperuricemia and gout.
Luk AJ; Simkin PA
Am J Manag Care; 2005 Nov; 11(15 Suppl):S435-42; quiz S465-8. PubMed ID: 16300457
[TBL] [Abstract][Full Text] [Related]
14. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options.
Bardin T; Richette P
BMC Med; 2017 Jul; 15(1):123. PubMed ID: 28669352
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of gout.
Weaver AL
Cleve Clin J Med; 2008 Jul; 75 Suppl 5():S9-12. PubMed ID: 18819329
[TBL] [Abstract][Full Text] [Related]
16. [Gout].
Scuiller A; Pascart T; Bernard A; Oehler E
Rev Med Interne; 2020 Jun; 41(6):396-403. PubMed ID: 32201015
[TBL] [Abstract][Full Text] [Related]
17. Secular trends in the incidence and prevalence of gout in Denmark from 1995 to 2015: a nationwide register-based study.
Zobbe K; Prieto-Alhambra D; Cordtz R; Højgaard P; Hindrup JS; Kristensen LE; Dreyer L
Rheumatology (Oxford); 2019 May; 58(5):836-839. PubMed ID: 30590724
[TBL] [Abstract][Full Text] [Related]
18. Gout epidemiology and comorbidities.
Singh JA; Gaffo A
Semin Arthritis Rheum; 2020 Jun; 50(3S):S11-S16. PubMed ID: 32620196
[TBL] [Abstract][Full Text] [Related]
19. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study.
Choi HK; Atkinson K; Karlson EW; Curhan G
Arch Intern Med; 2005 Apr; 165(7):742-8. PubMed ID: 15824292
[TBL] [Abstract][Full Text] [Related]
20. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease.
Borghi C; Agabiti-Rosei E; Johnson RJ; Kielstein JT; Lurbe E; Mancia G; Redon J; Stack AG; Tsioufis KP
Eur J Intern Med; 2020 Oct; 80():1-11. PubMed ID: 32739239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
